Mitcham, United Kingdom

Ahmed Mohammed Jehanli

This inventor holds 1 USPTO granted patent. Top assignee: Trigen Gmbh. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ahmed Mohammed Jehanli. Retrieved from https://idiyas.com/inventor/ahmed-mohammed-jehanli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ahmed Mohammed Jehanli: Innovator in Peptide Analogues

Introduction

Ahmed Mohammed Jehanli is a notable inventor based in Mitcham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of peptide analogues that have potential applications in cell growth and chemotaxis.

Latest Patents

One of his key patents is focused on platelet-derived growth factor analogues. This patent describes novel peptide analogues of platelet-derived growth factor, which can be used to inhibit or stimulate the growth and/or chemotaxis of cells, such as smooth muscle cells. The patent also includes compositions of matter that comprise these peptide analogues. Ahmed holds 1 patent in this area.

Career Highlights

Ahmed is currently employed at Trigen GmbH, where he continues to work on innovative solutions in the field of biotechnology. His expertise in peptide analogues has positioned him as a valuable asset in his company.

Collaborations

Throughout his career, Ahmed has collaborated with talented individuals such as Geeta Patel and Yemisi Olabiran. These collaborations have further enhanced his research and development efforts.

Conclusion

Ahmed Mohammed Jehanli is a distinguished inventor whose work on peptide analogues has the potential to impact various biological applications. His contributions to the field of biotechnology are noteworthy and continue to inspire innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…